148 related articles for article (PubMed ID: 19072290)
1. Marrow cell infusion attenuates vascular remodeling in a murine model of monocrotaline-induced pulmonary hypertension.
Aliotta JM; Keaney PJ; Warburton RR; DelTatto M; Dooner MS; Passero MA; Quesenberry PJ; Klinger JR
Stem Cells Dev; 2009 Jun; 18(5):773-82. PubMed ID: 19072290
[TBL] [Abstract][Full Text] [Related]
2. Induction of pulmonary hypertensive changes by extracellular vesicles from monocrotaline-treated mice.
Aliotta JM; Pereira M; Amaral A; Sorokina A; Igbinoba Z; Hasslinger A; El-Bizri R; Rounds SI; Quesenberry PJ; Klinger JR
Cardiovasc Res; 2013 Dec; 100(3):354-62. PubMed ID: 23867631
[TBL] [Abstract][Full Text] [Related]
3. Bone Marrow Endothelial Progenitor Cells Are the Cellular Mediators of Pulmonary Hypertension in the Murine Monocrotaline Injury Model.
Aliotta JM; Pereira M; Wen S; Dooner MS; Del Tatto M; Papa E; Cheng Y; Goldberg L; Ventetuolo CE; Liang O; Klinger JR; Quesenberry PJ
Stem Cells Transl Med; 2017 Jul; 6(7):1595-1606. PubMed ID: 28474513
[TBL] [Abstract][Full Text] [Related]
4. Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice.
Aliotta JM; Pereira M; Wen S; Dooner MS; Del Tatto M; Papa E; Goldberg LR; Baird GL; Ventetuolo CE; Quesenberry PJ; Klinger JR
Cardiovasc Res; 2016 Jun; 110(3):319-30. PubMed ID: 26980205
[TBL] [Abstract][Full Text] [Related]
5. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
[TBL] [Abstract][Full Text] [Related]
6. Estradiol metabolites attenuate monocrotaline-induced pulmonary hypertension in rats.
Tofovic SP; Salah EM; Mady HH; Jackson EK; Melhem MF
J Cardiovasc Pharmacol; 2005 Oct; 46(4):430-7. PubMed ID: 16160593
[TBL] [Abstract][Full Text] [Related]
7. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
[TBL] [Abstract][Full Text] [Related]
8. Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice.
Raoul W; Wagner-Ballon O; Saber G; Hulin A; Marcos E; Giraudier S; Vainchenker W; Adnot S; Eddahibi S; Maitre B
Respir Res; 2007 Jan; 8(1):8. PubMed ID: 17263874
[TBL] [Abstract][Full Text] [Related]
9. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats.
Yip HK; Chang LT; Sun CK; Sheu JJ; Chiang CH; Youssef AA; Lee FY; Wu CJ; Fu M
Crit Care Med; 2008 Mar; 36(3):873-80. PubMed ID: 18431275
[TBL] [Abstract][Full Text] [Related]
10. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of monocrotaline-induced pulmonary hypertension by luminal adeno-associated virus serotype 9 gene transfer of prostacyclin synthase.
Gubrij IB; Martin SR; Pangle AK; Kurten R; Johnson LG
Hum Gene Ther; 2014 Jun; 25(6):498-505. PubMed ID: 24512101
[TBL] [Abstract][Full Text] [Related]
12. Soluble guanylate cyclase stimulator, trans-4-methoxy-β-nitrostyrene, has a beneficial effect in monocrotaline-induced pulmonary arterial hypertension in rats.
Gonzaga-Costa K; Vasconcelos-Silva AA; Rodrigues-Silva MJ; Rebouça CDSM; Duarte GP; Borges RS; Magalhães PJC; Lahlou S
Eur J Pharmacol; 2021 Apr; 897():173948. PubMed ID: 33609564
[TBL] [Abstract][Full Text] [Related]
13. Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension.
Henriques-Coelho T; Correia-Pinto J; Roncon-Albuquerque R; Baptista MJ; Lourenço AP; Oliveira SM; Brandão-Nogueira A; Teles A; Fortunato JM; Leite-Moreira AF
Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2885-90. PubMed ID: 15331358
[TBL] [Abstract][Full Text] [Related]
14. Altered mTOR and Beclin-1 mediated autophagic activation during right ventricular remodeling in monocrotaline-induced pulmonary hypertension.
Deng Y; Wu W; Guo S; Chen Y; Liu C; Gao X; Wei B
Respir Res; 2017 Mar; 18(1):53. PubMed ID: 28340591
[TBL] [Abstract][Full Text] [Related]
15. Prolonged inhaled NO attenuates hypoxic, but not monocrotaline-induced, pulmonary vascular remodeling in rats.
Horstman DJ; Frank DU; Rich GF
Anesth Analg; 1998 Jan; 86(1):74-81. PubMed ID: 9428855
[TBL] [Abstract][Full Text] [Related]
16. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
Hill NS; Warburton RR; Pietras L; Klinger JR
J Appl Physiol (1985); 1997 Oct; 83(4):1209-15. PubMed ID: 9338430
[TBL] [Abstract][Full Text] [Related]
17. Syngeneic bone marrow mononuclear cells improve pulmonary arterial hypertension through vascular endothelial growth factor upregulation.
Yoshida H; Kitaichi T; Urata M; Kurobe H; Kanbara T; Motoki T; Kitagawa T
Ann Thorac Surg; 2009 Aug; 88(2):418-24. PubMed ID: 19632386
[TBL] [Abstract][Full Text] [Related]
18. Progesterone inhibits vascular remodeling and attenuates monocrotaline-induced pulmonary hypertension in estrogen-deficient rats.
Tofovic PS; Zhang X; Petrusevska G
Prilozi; 2009 Jul; 30(1):25-44. PubMed ID: 19736529
[TBL] [Abstract][Full Text] [Related]
19. Role of inhibition of nitric oxide production in monocrotaline-induced pulmonary hypertension.
Mathew R; Gloster ES; Sundararajan T; Thompson CI; Zeballos GA; Gewitz MH
J Appl Physiol (1985); 1997 May; 82(5):1493-8. PubMed ID: 9134898
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous Carbon Dioxide Treatment Using a Gas Mist Generator Attenuates the Development of Right Ventricular Dysfunction in Monocrotaline-induced Pulmonary Hypertensive Rats.
Yamaguchi T; Izumi Y; Yamazaki T; Nakamura Y; Sano S; Shiota M; Miura K; Iwao H; Yoshiyama M
Osaka City Med J; 2015 Jun; 61(1):31-41. PubMed ID: 26434103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
